Asker Healthcare Group ABOSTO:ASKER +1.13%13 ROE % is 11.53% as of Mar. 2026, which is 10% above its 10-year median of 10.46. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 113 Medical Distribution companies, Asker Healthcare Group AB ranks better than 64.6% on this metric.
The historical rank and industry rank for Asker Healthcare Group AB's ROE % or its related term are showing as below:
OSTO:ASKER'
s ROE % Range Over the Past 10 Years
Min: 7.02 Med: 10.46 Max: 15.56
Current: 9.15
During the past 4 years, Asker Healthcare Group AB's highest ROE % was 15.56%. The lowest was 7.02%. And the median was 10.46%.
OSTO:ASKER's ROE % is ranked better than 64.6% of 113
companies
in the Medical Distribution industry
Industry Median: 7.1
vs OSTO:ASKER: 9.15
Asker Healthcare Group AB (OSTO:ASKER) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Asker Healthcare Group AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's ROE % distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Asker Healthcare Group AB (OSTO:ASKER) has a ROE % of 11.53% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Asker Healthcare Group AB and its competitors. This is 10% above median its historical median of 10.46. Over the past decade, Asker Healthcare Group AB's ROE % has ranged from 7.02 to 15.56. According to the industry distribution chart, Asker Healthcare Group AB ranks #40 out of 113 companies in the Medical Distribution industry, placing it in the top 35.4%.
Is Asker Healthcare Group AB's ROE % too high?
Asker Healthcare Group AB's current ROE % of 11.53% is 10% above median its 10-year median of 10.46. Over the past 10 years, this metric has ranged from a low of 7.02 to a high of 15.56. The Medical Distribution industry median ROE % is 7.10. Asker Healthcare Group AB's value of 11.53% is 62.4% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #40 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's ROE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #40 out of 113 companies for ROE %. This puts Asker Healthcare Group AB in the upper half of its industry. The industry median ROE % is 7.10. Asker Healthcare Group AB's value of 11.53% is 62.4% above this benchmark. Historically, Asker Healthcare Group AB's own ROE % has ranged from 7.02 to 15.56 over the past decade. While the company's 10-year median is 10.46 vs. the industry median of 7.10, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current ROE % of 11.53% is 62.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current ROE % is 11.53%, which is 10% above median its own 10-year median of 10.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current ROE % of 11.53%. The current ROE % is 11.53%, which is 10% above median its 10-year median of 10.46 and 62.4% above the Medical Distribution industry median of 7.10. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current ROE % is 11.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
